CDIO CDIO
Company Profile ↓Company Overview
CDIO (CDIO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 101.4% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.06.
Recent Developments
- Dec 2025 Revenue of $14.82K (-57.5% YoY); net profit $-6.50M.
- Trailing 12 Months Year-on-year growth — revenue -57.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 101.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 101.40% |
| 1 Year: | -57.51% |
Stock Price Performance
| 1 Year: | -56.20% |
| 6 Months: | +28.68% |
| 3 Months: | -4.37% |
| 1 Month: | -8.38% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)51.07 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 101.4% over 5 years.
CONS
- Trading 73.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1.73K | 10.03K | 15.93K | 7.87K | 6.58K | 940 | 7.47K | 2.85K | 2.68K |
| Operating Income | -227.09K | -786.96K | -1.15M | -1.70M | -2.55M | -1.44M | -4.16M | -1.28M | -1.41M | -1.63M | -1.68M | -1.71M | -1.78M |
| Net Income | -290.06K | -842.00K | -1.15M | -1.03M | -4.02M | -1.93M | -4.16M | -1.29M | -1.41M | -1.64M | -1.68M | -1.71M | -1.79M |
| Diluted EPS | -0.07 | -0.16 | -0.17 | -0.11 | -0.39 | -0.16 | -5.93 | -1.71 | -1.73 | -0.97 | -0.97 | -0.98 | -0.63 |
| R&D Expense | 1.13K | 5.04K | 3.19K | 86.67K | 12.32K | 38.71K | 10.84K | 7.28K | 5.25K | 118.78K | 163.10K | 189.05K | 129.78K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 901 | 950 | 17.07K | 34.89K | 14.82K |
| Operating Income | -620.45K | -4.55M | -7.24M | -8.37M | -6.48M |
| Net Income | -620.45K | -4.66M | -8.38M | -8.38M | -6.50M |
| Diluted EPS | -0.53 | -1.51 | -0.66 | -9.35 | -3.71 |
| R&D Expense | 31.47K | 40.45K | 145.18K | 227.97K | 641.21K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 1.10M | 6.25M | 4.46M | 10.62M | 7.77M |
| Total Equity | 60.37K | 1.07M | 4.30M | 2.96M | 9.56M | 6.97M |
| Cash & Equivalents | - | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | - | 33.88K | 1.95M | 1.50M | 1.06M | 793.06K |
| Current Liabilities | - | 124.43K | 1.95M | 841.14K | 631.70K | 604.84K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -5.09M | -5.67M | -4.99M | -5.73M |
| Investing Cash Flow | - | -368.00K | -794.29K | -404.19K | -419.31K |
| Financing Cash Flow | - | 9.06M | 3.63M | 11.94M | 3.43M |
| Capital Expenditure | - | -76.15K | -794.29K | -404.19K | -419.31K |
| Free Cash Flow | - | -5.17M | -6.47M | -5.40M | -6.15M |
| Net Change in Cash | - | 3.60M | -2.83M | 6.54M | -2.72M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | -68,862.2% | -478,784.3% | -42,440.4% | -23,977.9% | -43,737.5% |
| Net Margin % | -68,862.2% | -490,630.0% | -49,087.8% | -24,028.2% | -43,832.5% |
| ROE % | -58.1% | -108.4% | -283.2% | -87.7% | -93.2% |
| ROCE % | -63.5% | -105.7% | -200.0% | -83.8% | -90.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CDIO
Cardio Diagnostics to discuss heart disease tests Aug. 20 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPYjlTTHYxMUF1SV9wc0o1RFpTMGpTTG85TVd6UEppVjNjUGF6NC1VYVV3ak9qT2dJQ2EtN3NZVHg1b05BaEF3ajVnM0lnQmpLeXozNW9McTZUdGtucDVjaUxBY0hHZ1RZMTlNSzF1ZTM2bkZEaWhLRXBxaFdYdTlfZGoyeVQxckV2MHAxZE…
CDIO Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9mVF80Q1B5MVNRYmxjek1kX19rNS04ZVdMOXQtZG5Ebnd1UnZXQUZSaWp3OW9vZ1NybG9kRWNRODgycEk0Unh5RGc0YTd5dUMtMkZVY3Q0ZG5WWHJLWWc?oc=5" target="_blank">CDIO Should I Buy</a> <font c…
CDIO Shares Gain Momentum with AI-Powered Cardiac Innovations Announcement - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxORDdjOUFQUVZBLWhSMGIxOEhFUDZ4bUwtRlFOWDMxWkdDM2tyX3JpTnNScjNKNU8wNmlJbldVUUxudEtoZ21fMS1OZlI3VEdMRE5zNVhnelBaSWlPNmc1VTZsTFFaYThrYXhkcldRSjVVZmhyZmFDSXpfc0pTejM5Ql82WVlfUmQ0NGlpOU…
Market Movers | Winners: PED, BIAF, AIFF | Losers: CMCT, KLC, CDIO - Trefis
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNQUxrS19ubkEtN3NVbmpqMHJ2V1J4ZWJSaXZLSzk3X3lnQXFRR1p1WGtJSElDRV9TRmg1aGN6dGQwNzNOeXdnNUNGd21rQ05IaGQ3RHVhNjF1UGVCUUIwMlAwR1Fqei1BNmt4YjRjYnRxWHY5VEtnaUw0VTk1TmZQbzktSGNRVnRfN2VONU…
Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - NewMediaWire
<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxOYXhuT3N0ZndvUmZtVHBodTlPaVlEeU5tdWYyY0dHTFJlTTVqQnU3LTRnUTlFRVYtbUsxRHRWZTlzYXFITng4ZDg2WVNScHRZcmlYeFhEeXA3YzZCaC1MLVRJRmNTZFBXWm1yOFdJblozenVSWG1CSUFscERDSEdvS2t0bWZmbXpjbXVNNH…
Which stocks have an unusual volume on Friday? - ChartMill
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOM2hxMXIxRXB3d1NrR3FFSksxV2JWNk9vVGZYR3pzRWQxczlXSUZCZzNHaFFPZU00S01haHliNlFXSGRRczVNVU1Zc0hJbGxFSkRKR2xsV1puUFhaMGg0R0s0UWd1TjhtSmFLeEhHMEpXaDBwYU9DbGU5UHVUN2hSX3F5WWRteXI1VkVsUW…
CDIO — Frequently Asked Questions
What is the current share price of CDIO?
As of 2026-08-05 17:25 PDT, CDIO trades at $1.75 on NASDAQ/NYSE. Its 52-week range is $1.05 to $6.55.
What is the P/E ratio of CDIO?
CDIO trades at a trailing price-to-earnings (P/E) ratio of -0.47.
What is the return on equity (ROE) of CDIO?
CDIO has a return on equity (ROE) of -93.19%. Its return on capital employed (ROCE) is -90.54%.
Is CDIO a good stock to buy?
This page provides a data-driven analysis of CDIO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.